EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0

被引：0

作者：

Silvia Morbelli

Giuseppe Esposito

Javier Arbizu

Henryk Barthel

Ronald Boellaard

Nico I. Bohnen

David J Brooks

Jacques Darcourt

John C. Dickson

David Douglas

Alexander Drzezga

Jacob Dubroff

Ozgul Ekmekcioglu

Valentina Garibotto

Peter Herscovitch

Phillip Kuo

Adriaan Lammertsma

Sabina Pappata

Iván Peñuelas

John Seibyl

Franck Semah

Livia Tossici-Bolt

Elsmarieke Van de Giessen

Koen Van Laere

Andrea Varrone

Michele Wanner

George Zubal

Ian Law

机构：

[1] IRCCS Ospedale Policlinico San Martino,Nuclear Medicine Unit, IRCCS Ospedale Policlinico San Martino, Department of Health Sciences

[2] University of Genoa,Nuclear Medicine, Department of Radiology

[3] Medstar Georgetown University Hospital,Department of Nuclear Medicine

[4] University of Navarra,Department of Nuclear Medicine

[5] Clinica Universidad de Navarra,Department of Radiology and Nuclear Medicine

[6] IdiSNA,Departments Radiology & Neurology

[7] Leipzig University,Department of Nuclear Medicine

[8] Amsterdam UMC,Institute of Neuroscience

[9] Vrije Universiteit Amsterdam,Nuclear Medicine, Department of imaging, Centre Antoine Lacassagne

[10] NeuroScience,Institute of Nuclear Medicine

[11] University of Michigan & Ann Arbor Veterans Medical Center,Department of Nuclear Medicine and Neuroradiology

[12] Aarhus University,Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne

[13] University of Newcastle upon Tyne,Molecular Organization of the Brain, Research Center Jülich

[14] Université Cote d’Azur,Division of Nuclear Medicine and Clinical Molecular Imaging in the Department of Radiology

[15] University College London Hospitals NHS Foundation Trust,Department of Nuclear Medicine

[16] Stanford University,NIMTLab, Faculty of Medicine

[17] University of Cologne,Division of Nuclear Medicine and Molecular Imaging

[18] German Center for Neurodegenerative Diseases (DZNE),Positron Emission Tomography Department

[19] Institute of Neuroscience and Medicine (INM-2),Departments of Medical Imaging, Medicine and Biomedical Engineering

[20] Perelman School of Medicine at the University of Pennsylvania,National Council of Research

[21] Sisli Etfal Education and Research Hospital,Nuclear Medicine Department

[22] Geneva University,Medical Physics

[23] Geneva University Hospitals,Radiology and Nuclear Medicine

[24] NIH/CC,Nuclear Medicine and PET

[25] University of Arizona,MR Unit, Department of Imaging and Pathology

[26] Institute of Biostructure and Bioimaging,Centre for Psychiatry Research, Department of Clinical Neuroscience

[27] Institute for Neurodegenerative Disorders,Nuclear Medicine and CT

[28] University Hospital,Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet

[29] University Hospital Southampton NHS Foundation Trust,undefined

[30] Amsterdam UMC,undefined

[31] University of Amsterdam,undefined

[32] University Hospital and KU Leuven,undefined

[33] Karolinska Institutet & Stockholm Health Care Services,undefined

[34] Region Stockholm,undefined

[35] University of Washington,undefined

[36] NIH/NIBIB,undefined

[37] University of Copenhagen,undefined

来源：

European Journal of Nuclear Medicine and Molecular Imaging | 2020年 / 47卷

关键词：

Brain; DAT; DOPA; PET; SPECT; Parkinson; Parkinsonian syndromes;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1885 / 1912

页数：27

共 858 条

[1]

Berardelli A(2013)EFNS/MDS-ES/ENS recommendations for the diagnosis of Parkinson's disease Eur J Neurol 20 16-34

[2]

Wenning GK(2003)Clinical overview of the synucleinopathies Mov Disord 18 S21-S27

[3]

Antonini A(2013)Criteria for the diagnosis of corticobasal degeneration Neurology. 80 496-503

[4]

Berg D(2017)Movement Disorder Society-endorsed PSP Study Group. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria Mov Disord 32 853-864

[5]

Bloem BR(2001)What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study Neurology. 57 S34-S38

[6]

Bonifati V(2007)SPECT imaging of the dopaminergic system in (premotor) Parkinson’s disease Parkinsonism Relat Disorders 13 S425-S428

[7]

Martí MJ(2006)PET tracers for imaging of the dopaminergic system Curr Med Chem 13 2139-2153

[8]

Tolosa E(2004)PET and SPECT functional imaging studies in Parkinsonian syndromes: from the lesion to its consequences Neuroimage. 23 1-16

[9]

Campdelacreu J(2010)EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2 Eur J Nucl Med Mol Imaging 37 434-442

[10]

Armstrong MJ(2002)Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP Mov Disord 17 303-312

← 1 2 3 4 5 6 7 8 9 10 →